Stock listing

A2N9D9 Stock Price, News, Filings & Events — Moderna, Inc.

Selected listing: A2N9D9 · LSX · EUR · DE

A2N9D9:LSX is the public stock listing for Moderna, Inc. The company is focused on developing mRNA-based therapeutics and vaccines, with a significant emphasis on addressing infectious diseases and cancer. Recent news highlights their ongoing research and development efforts, as well as updates on regulatory filings and partnerships. Investors can stay informed about upcoming events and market trends that may impact the company's performance.

A2N9D9:LSXEURDEUpdated July 21, 2026
Moderna, Inc. logo
Ticker
A2N9D9:LSX
Asset type
Stock
Market cap
$24.53B
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Moderna, Inc. A2N9D9:LSX stock context

A2N9D9:LSX is the public stock listing for Moderna, Inc. The company is focused on developing mRNA-based therapeutics and vaccines, with a significant emphasis on addressing infectious diseases and cancer. Recent news highlights their ongoing research and development efforts, as well as updates on regulatory filings and partnerships. Investors can stay informed about upcoming events and market trends that may impact the company's performance.

Research Moderna, Inc.

Alternate listings